Loading...
In 2004, the Danish National Board of Health recommended that pregnant women be offered first-trimester Down syndrome risk assessment based on maternal age, nuchal translucency, and a double test consisting of serum-free β-human chorionic gonadotropin and pregnancy-associated plasma protein A (similar first-trimester screening is recommended in the U.S. [JW Womens Health Mar 8 2007]). Chorionic villus sampling or amniocentesis was recommended for women with calculated risks above 1:250 to 1:400 (cutoffs varied by county).
Now, analysis of Danish national health data from 2000 through 2006 shows that the proportion of Down syndrome cases diagnosed prenatally rose from 53% to 79% and the number of invasive diagnostic procedures was halved duri…